Immunochemotherapy with OK-432 may improve survival for people with curatively resected gastric cancer

Cancer Treat Rev. 2003 Feb;29(1):73-5. doi: 10.1016/s0305-7372(02)00124-x.
No abstract available

Publication types

  • Comment